Skip to main content
. 2013 Nov 21;8(11):e79751. doi: 10.1371/journal.pone.0079751

Figure 2. Histopathological changes in the urinary bladders of chronic EAC mice treated with anti-CXCL10 Ab.

Figure 2

Bladder sections from control or anti-CXCL10 Ab groups are shown at different magnifications (A, C, E, G X30; B, D, F, H X100). Panel F shows sections from EAC-induced mice treated with control Ab to illustrate inflamed bladders characterized by differences in mucosal wall thickness, enlargement of the mucosal layer, and leukocyte infiltration. Panel H shows marked improvement after anti-CXCL10 Ab treatment.